Aton, Bristol-Myers sales and marketing update

Bristol-Myers granted Aton Pharma exclusive rights to market Lodosyn carbidopa in the U.S. The aromatic amino acid decarboxylation inhibitor is approved for use with carbidopa-levodopa or with levodop...